Literature DB >> 34131870

Vacuum-Assisted Closure and Skin Grafting Combined with Amphotericin B for Successful Treatment of an Immunocompromised Patient with Cutaneous Mucormycosis Caused by Mucor irregularis: A Case Report and Literature Review.

Xuhua Tang1, Penghao Guo2, Hioteng Wong1, Jiahui Xie3, Jiande Han1, Yingbin Xu4, Hui Zhou5.   

Abstract

Cutaneous mucormycosis caused by Mucor irregularis (M. irregularis) is a rare condition that typically occurs in immunocompetent patients. Herein, we describe an immunocompromised patient with cutaneous M. irregularis infection who was successfully treated with debridement combined with vacuum assisted closure (VAC) negative pressure technique and split-thickness skin grafting. We present this case owing to its complexity and rarity and the successful treatment with surgical therapy. A 58-year-old man presented to our hospital with a history of skin ulcers and eschar on the right lower leg since two months. He had been receiving methylprednisolone therapy for bullous pemphigoid that occurred five months prior to the present lesions. Histopathological examination of a right leg lesion showed broad, branching hyphae in the dermis. Fungal culture and subsequent molecular cytogenetic analysis identified the pathogen as M. irregularis. After admission, methylprednisolone was gradually tapered and systemic treatment with amphotericin B (total dose 615 mg) initiated along with others supportive therapies. However, the ulcers showed no improvement, and amphotericin B had to be discontinued owing to development of renal dysfunction. After extensive surgical debridement combined with VAC and skin grafting, his skin ulcers were healed; subsequent fungal cultures of the lesions were negative. The patient exhibited no signs of recurrence at 36-month follow-up. Twenty-six cases with M. irregularis-associated cutaneous mucormycosis in literature were reviewed.

Entities:  

Keywords:  Amphotericin B; Cutaneous mucormycosis; Debridement; Mucor irregularis; Negative-pressure wound therapy; Rhizomucor variabilis

Year:  2021        PMID: 34131870     DOI: 10.1007/s11046-021-00551-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  1 in total

1.  Heterothallic mating in Mucor irregularis and first isolate of the species outside of Asia.

Authors:  Wiley A Schell; Kerry O'Donnell; J Andrew Alspaugh
Journal:  Med Mycol       Date:  2011-04-01       Impact factor: 4.076

  1 in total
  1 in total

1.  [Treatment of a terbinafine-resistant trichophyton mentagrophytes type VIII].

Authors:  A Gawaz; P Nenoff; S Uhrlaß; M Schaller
Journal:  Hautarzt       Date:  2021-07-09       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.